000 01504 a2200385 4500
005 20250514184225.0
264 0 _c20040615
008 200406s 0 0 eng d
022 _a1120-009X
024 7 _a10.1179/joc.2004.16.1.13
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchito, G C
245 0 0 _aComparative activity of telithromycin against macrolide-resistant isolates of Streptococcus pneumoniae: results of two years of the PROTEKT surveillance study.
_h[electronic resource]
260 _bJournal of chemotherapy (Florence, Italy)
_cFeb 2004
300 _a13-22 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAcetamides
_xpharmacology
650 0 4 _aAnti-Bacterial Agents
_xpharmacology
650 0 4 _aAnti-Infective Agents
_xpharmacology
650 0 4 _aDrug Resistance, Bacterial
650 0 4 _aHumans
650 0 4 _aKetolides
650 0 4 _aLinezolid
650 0 4 _aMacrolides
_xpharmacology
650 0 4 _aOxazolidinones
_xpharmacology
650 0 4 _aPneumococcal Infections
_xdrug therapy
650 0 4 _aPopulation Surveillance
650 0 4 _aStreptococcus pneumoniae
_xdrug effects
650 0 4 _aVancomycin
_xpharmacology
700 1 _aMarchese, A
700 1 _aElkharrat, D
700 1 _aFarrell, D J
773 0 _tJournal of chemotherapy (Florence, Italy)
_gvol. 16
_gno. 1
_gp. 13-22
856 4 0 _uhttps://doi.org/10.1179/joc.2004.16.1.13
_zAvailable from publisher's website
999 _c14792247
_d14792247